Laso Biotech (拉索生物)

Your Alternative Genotyping Solutions

Headquarters
Suzhou
Employees
11–50
Business Model
B2B

About

Suzhou LASO Biotech is a China-based pioneer in genotyping technology, and the first company in China to independently develop, produce, and commercialize a high-throughput microarray platform. The company provides end-to-end integrated genotyping solutions — encompassing microarray scanners, customizable arrays, reagents, software, and algorithms — serving agricultural genomics, livestock breeding, and human genetics research markets globally. LASO Biotech holds over 22 invention patents and 1 medical device registration certificate, making it the company with the most comprehensive independently-controlled IP portfolio for microarrays under Chinese law.

Summary

Laso Biotech (拉索生物) is a Biotech company based in Suzhou, China.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Laso Biotech (拉索生物) on Indexed.vc
<a href="https://indexed.vc/companies/laso-biotech"><img src="https://indexed.vc/api/badge/company/laso-biotech" alt="Laso Biotech (拉索生物) on Indexed.vc" width="260" height="76" /></a>